Editas Medicine

Developer of therapeutics for rare genetic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups257 employees language editasmedicine.com

Registered entities

Social engagement

Social engagement: 52.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

23 investors on record; lead investors include Array; 1 has since exited.

Investor typeCountShare
Venture capital939%
Private equity29%
Bank & private debt29%
Other / undisclosed1043%

Hiring activity

Hires periodically

5 roles tracked across 3 of the last 12 months

11 May 2026 · Senior Information Security Engineer · Cambridge

22 Apr 2026 · Scientist I, Assay Development in vitro/in vivo Pharmacology · Cambridge

22 Oct 2025 · Senior Director, Genomics & Bioinformatics · Cambridge

10 Oct 2025 · Director, Toxicology · Cambridge

7 Oct 2025 · Manager, Procurement · Cambridge

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Event
European Congress on Biotechnology
26 Jun 2026
Event
Cell & Gene Therapy World Asia 2026
24 Jun 2026
Event
European Congress on Biotechnology
Coming soon